Dolutegravir-Based or Low-Dose Efavirenz–Based Regimen for the Treatment of HIV-1

Bringing migration research under one roof.

Funded by Led by

This project was made possible thanks to funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement Ares(2017) 5627812-77012.